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Background: Lymphotoxin- (LT-), interleukin-6 (IL-6) and
nterleukin-1beta (IL-1) are proinﬂammatory cytokines playing
mportant roles in immunity against Leishmania infection and the
utcome of the disease. As cytokine productions are under the
enetic control, this study tried to ﬁnd any probable relationship
etween these cytokinegenepolymorphismsand the susceptibility
o visceral leishmaniasis (VL) in Iranian pediatric patients.
Methods: 95 pediatric patients involved with visceral leishma-
iasis and 128 non-relative healthy people, from the same area as
he patients, were genotyped for LT- (+252 A/G), IL-6 (-174C/G)
nd IL-1 (+3953 T/C and -511T/C) gene polymorphisms using
olymerase chain reaction-restriction fragment length polymor-
hism (PCR-RFLP).
Results:Therewasnot found any signiﬁcant differences in allele
nd genotype frequencies of LT- (+252 A/G), IL-6 (-174C/G) and
L-1 (+3953) among the study groups. However, the frequency
f IL-1 -511TT genotype was higher in the controls (P =0.0004)
hile the frequency of IL-1 -511CC genotype and C allele were
igher in the patients (P =0.008 and P=0.00006, respectively). Fur-
hermore, IL-1 CC (-511/ +3953) haplotype was more frequent in
L patients compared with the controls (P =0.0002) and the distri-
ution of TT haplotype was higher in controls compared with the
atients (P =0.003).
Conclusion: Based on the results IL-1 -511C allele, CC geno-
ype and CC (-511/ +3953) haplotype could be considered as the
usceptibility factors for visceral leishmaniasis while IL-1 -511TT
enotype, Tallele andTThaplotype (-511/ +3953)mightbecounted
s the inﬂuential factors for resistance to the disease.
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Malaria: incidence, clinical proﬁle, complications, treatment
options: study from a rural medical college hospital in south
India. (Any case of fever is malaria until proven otherwise: still
holds true in India!)
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Background: Malaria is the commonest parasitic infection in
India. TheNational Vector BorneDisease Control Programme (NVB-
DCP) reports 2 million parasite positive cases a year. The WHO
estimates 100 million cases in the south East Asian Region, 70% of
these in India. Independent studies by the IndianCouncil ofMedical
Research have unequivocally established that malaria incidence is
hugely under-estimated.
Epidemiology is complex because of geo-ecological diversity,
multi-ethnicity, and wide distribution of anopheline malaria.
The countrywide presence is facilitated by inter-and intra-state
population movement.
A shift in the clinical proﬁle inpatientswith complicatedmalaria
has been observed with multiple organ dysfunction becoming a
common feature.
Anti-malarial drugs available include chloroquine, quinine, and
artemesinin compounds.
Methods: To assess the incidence of malaria, clinical proﬁle and
course of the disease, and response to different treatment options
available.
All cases of conﬁrmed malaria, clinically diagnosed malaria and
treated with anti-malarial drugs from January 2011 to December
2011 were analysed for fever pattern, clinical features, hospitaliza-
tion, complications and mortality rate.
Results:A total of 174 caseswere diagnosed / treated asmalaria.
93 were male and 81 female. Complicated malaria was seen in 38
cases (21.83%) with positivity in 20 cases. Mortality was 04.59% of
clinicalmalaria cases, all admittedwithmultiple organ dysfunction
syndrome, no mortality in conﬁrmed cases. Of the remaining 136
cases malarial was conﬁrmed in 42, while 94 were clinical malaria.
18 were positive for P.falciparum, 18 for P.vivax. 6 patients were
positive for both falciparum and vivax. All patients were treated
with anti-malarial with recovery. Chlroquine was used in those
diagnosed as clinical malaria, followed by quinine and Artemisinin
in both clinical and conﬁrmed cases depending upon the clinical
severity.
Conclusion: Malaria was positive in only 35.63%, remaining
being clinically / therapeutically proven malaria cases. Clinical
malaria patients had palpable spleen as clinical sign, along with
fever, chills and rigors.
Clinical suspicion and early initiation of treatment helps in
recovery.
